Progression-free survival in patients with 68Ga-PSMA-PET-directed SBRT for lymph node oligometastases.

Anita M Werensteijn-HoninghAnne F J WeversMax Peters Petra S Kroon Martijn P W Intven Wietse S C Eppinga Ina M Jürgenliemk-Schulz

Published in: Acta oncologica (Stockholm, Sweden) (2021)

A median PFS of 16 months was attained after SBRT for patients with PSMA-PET positive oligometastatic lymph nodes from prostate cancer. Higher pre-SBRT PSA, younger age and extrapelvic location were found to be predictors of shorter PFS.

Keyphrases

pet ct
lymph node
prostate cancer
radiation therapy
free survival
radical prostatectomy
positron emission tomography
sentinel lymph node
neoadjuvant chemotherapy
pet imaging
locally advanced